ClinicalTrials.gg
CompletedNCT05846932Updated Oct 2, 2026Results posted

Preliminary Efficacy of Occupational Therapy Integrating Horses on Self-regulation in Youth With Autism

An interventional study of OTEE HORS and OT Clinic in Autism Spectrum Disorder, sponsored by Colorado State University. Completed at 1 site in United States. Open to participants aged 6 Years to 11 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-02.

Sponsored by Colorado State University · Not applicable, Interventional, and Treatment

Updated Oct 2, 2026Results postedStudy documents posted+2 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
72
Allocation
Randomized
Ages
6 Years to 11 Years
Sex
All
01

Study summary

The goal of this clinical trial is to learn about occupational therapy integrating horses for autistic youth. The main questions it aims to answer are:

  • Does occupational therapy integrating horses improve self-regulation in autistic youth
  • Does occupational therapy integrating horses affect salivary cortisol and alpha-amylase

Participants will receive 10 weeks of occupational therapy, and will be asked to provide saliva samples each week.

Researchers will compare occupational therapy integrating horses to occupational therapy in a clinic to see if integrating horses affects self-regulation.

Read the detailed description

The goal of this project is to quantify the unique benefits of integrating horses in occupational therapy compared to occupational therapy in a clinic (i.e., OTEE HORS vs. OT Clinic) for improving self-regulation in youth with ASD.

To address both aims we will randomize 64 youth with ASD ages 6-11 years old to OTEE HORS or OT clinic.

Specific Aim 1: Examine the preliminary efficacy of OTEE HORS compared to OT Clinic on self-regulation. Hypotheses: The OTEE HORS group will demonstrate significantly larger improvements than the OT Clinic group in five domains of self-regulation (hyperactivity [primary], irritability, emotional reactivity, dysphoria, and individual goal attainment).

Specific Aim 2: Identify potential physiological mechanisms that explain how integration of horses in occupational therapy impacts self-regulation in youth with ASD. Hypotheses 2A \& B: The OTEE HORS group will demonstrate significantly larger decreases in salivary cortisol after each 60-minute therapy session and after the 10-week treatment course in comparison to the OT Clinic group. Hypotheses 2C \& 2D: The OTEE HORS group will demonstrate significantly greater increases in salivary alpha-amylase after each 60-minute therapy session, and significantly greater decreases in salivary alpha-amylase over time as measured after the 10-week treatment course in comparison to the OT Clinic group. Exploratory Hypothesis 2E: Changes in physiological measures will significantly correlate with changes in Aim 1 behavioral measures.

02

Conditions studied

  • Autism Spectrum Disorder

Keywords

  • occupational therapy
  • hippotherapy
  • equine-assisted services
  • self-regulation
03

In context

Autism Spectrum Disorder

1,724 studies on the registry are indexed under Autism Spectrum Disorder; 500 are open to participants now.

This study's enrollment of 72 is above the median of 52 across 1,368 interventional studies indexed under Autism Spectrum Disorder.

Browse Autism Spectrum Disorder studies →

Lead sponsor

Colorado State University is the lead sponsor of 117 studies on the registry; 19 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 3 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 11 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • meet clinical cut-offs for ASD on the Autism Diagnostic Observation Schedule, Second Edition(ADOS-2) and Social Communication Questionnaire (≥ 11)
  • nonverbal IQ≥65 on Leiter International Performance Scale Third Edition (Leiter-3)
  • verbally fluent defined by meeting standard administration criteria for ADOS-2 module 3
  • score >10 on the irritability subscale of the aberrant behavior checklist
  • able to tolerate a helmet and ride a horse for 10 minutes while following safety rules
  • and able to provide a saliva sample

Exclusion criteria

Exclusion Criteria:

  • weigh more than 200 pounds
  • smoke or regularly use
  • receive outpatient occupational therapy
  • have 10+ hours horseback riding experience in the previous 6 months
  • history of animal abuse or phobia of horses
  • have a sibling previously enrolled in the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
72 participants (actual)

Study arms

  • Experimental
    Occupational Therapy Integrating Horses

    10 weeks of occupational therapy focused on self-regulation skills, provided while participants are riding horses

    Behavioral: OTEE HORS

  • Active comparator
    Occupational Therapy in a Clinic

    10 weeks of occupational therapy focused on self-regulation skills, provided in a traditional clinic environment

    Behavioral: OT Clinic

Interventions

  • BehavioralOTEE HORS

    10 weeks of occupational therapy focused on teaching and practicing self-regulation skills, provided while participants are riding horses

  • BehavioralOT Clinic

    10 weeks of occupational therapy focused on teaching and practicing self-regulation skills, provided in a traditional clinic

06

What researchers measure

Primary outcomes

  1. Change in Hyperactivity

    The Hyperactivity subscale of the Aberrant Behavior Checklist, Second Edition (ABC-2) measures parent/caregiver-reported hyperactive and impulsive behaviors, including excessive activity, impulsivity, and difficulty remaining still or attending. The subscale consists of 16 items, with total scores ranging from 0-48. Higher scores indicate greater hyperactivity and more severe behavioral difficulties, while lower scores indicate less hyperactivity and better behavioral functioning. Item scores are summed to produce the subscale score.

    Time frame: Week 1 & Week 10

Secondary outcomes

  1. Change in Irritability

    The Irritability subscale of the Aberrant Behavior Checklist, Second Edition (ABC-2) measures behaviors associated with irritability, including aggression, self-injury, tantrums, and mood instability. The subscale consists of 15 items, with total scores ranging from 0-45. Higher scores indicate greater irritability and more severe behavioral difficulties, while lower scores indicate less irritability and better behavioral functioning. Items are rated based on the presence and severity of behaviors, and item scores are summed to produce the subscale score.

    Time frame: Week 1 & Week 10

  2. Change in Emotional Reactivity

    The Emotional Reactivity subscale of the Emotion Dysregulation Inventory (EDI) measures the tendency to experience intense, rapidly escalating, and prolonged negative emotional responses. T-scores are standardized scores derived from the raw Emotional Reactivity score and have a mean of 50 and standard deviation of 10 in the normative sample. Higher T-scores indicate greater emotional reactivity and more severe emotion dysregulation, while lower T-scores indicate less emotional reactivity and better emotional regulation.

    Time frame: Week 1 & Week 10

  3. Change in Dysphoria

    The Dysphoria subscale of the Emotion Dysregulation Inventory (EDI) measures symptoms of negative mood, including sadness, hopelessness, and emotional distress. T-scores are standardized scores derived from the raw Dysphoria score and have a mean of 50 and standard deviation of 10 in the normative sample. Higher T-scores indicate greater dysphoria and more severe negative mood symptoms, while lower T-scores indicate less dysphoria and better emotional well-being.

    Time frame: Week 1 & Week 10

  4. Change in Concentration of Salivary Cortisol

    Change in Concentration of Salivary Cortisol from before-session, after-session, and 20 mins after-session. Saliva samples from Weeks 2, 6, and 10 at pre-session, post-session, and post-session +20, were assayed for cortisol content and included in the linear mixed model analyses.

    Time frame: Pre-session, Post-session, Post-session + 20 min, averaged across Intervention Weeks 2, 6 and 10

  5. Change in Concentration of Salivary Alpha-amylase

    Change in concentration of salivary alpha-amylase from before-session, during-session, and 20 mins after-session. Saliva samples from Weeks 2, 6, and 10 at pre-session, within-session, and post-session +20, were assayed for alpha-amylase content and included in the linear mixed model analyses.

    Time frame: Pre-session, Within-session, Post-session + 20 min, averaged across Intervention Weeks 2, 6 and 10

  6. Emotional Awareness Goal Attainment

    Attainment of individualized emotional awareness goal. Goal attainment scales range from -2 to +2 where higher values indicate greater progress towards individual goal, level 0 indicates goal was met.

    Time frame: Week 10

  7. Self-regulation Tool Identification Goal Attainment

    Attainment of individualized goal related to identifying self-regulation tools. Goal attainment scales range from -2 to +2 where higher values indicate greater progress towards individual goal, level 0 indicates goal was met.

    Time frame: Week 10

  8. Self-regulation Tool Use Goal Attainment

    Attainment of individualized goal related to using self-regulation tools. Goal attainment scales range from -2 to +2 where higher values indicate greater progress towards individual goal, level 0 indicates goal was met.

    Time frame: Week 10

07

Results

Posted Oct 2, 2026
Limitations and caveats
This study was underpowered to detect many of the observed between-group effect sizes as the original power analysis estimated medium-large effect sizes. Finally, the study is limited by the high drop-out rate from the OT-ZOR Clinic intervention, and the resulting 2:1 randomization (Clinic: Equine) may have biased the sample with participants well-suited for the Clinic condition.

Participant flow

We recruited participants via flyers distributed via email listservs and at local events for disability/autism communities.

Participant flow — Overall Study
MilestoneOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Started3438
Completed3224
Not completed214
Withdrew: Withdrawal by subject214

Outcome measures

PrimaryChange in Hyperactivity

The Hyperactivity subscale of the Aberrant Behavior Checklist, Second Edition (ABC-2) measures parent/caregiver-reported hyperactive and impulsive behaviors, including excessive activity, impulsivity, and difficulty remaining still or attending. The subscale consists of 16 items, with total scores ranging from 0-48. Higher scores indicate greater hyperactivity and more severe behavioral difficulties, while lower scores indicate less hyperactivity and better behavioral functioning. Item scores are summed to produce the subscale score.

Time frame:
Week 1 & Week 10
Reported as:
Least squares mean · Scores on a Scale
Change in Hyperactivity
Scores on a ScaleOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Week 1 Hyperactivity25.09 (21.67 to 28.50)22.98 (19.19 to 26.77)
Week 10 Hyperactivity19.71 (16.29 to 23.12)19.99 (16.12 to 23.86)
Statistical analysis
  • Occupational Therapy Integrating Horses vs Occupational Therapy in a Clinic · Mixed Models Analysis · p = .264 · Mean difference (net): -2.39 · 95% CI -6.62 to 1.84Models included fixed effects for group, time, and the interaction of group-by-time with a random effect for score by participant ID.
  • Occupational Therapy Integrating Horses · Mixed Models Analysis · p = <0.001 · Mean difference (final values): -5.38Model included fixed effects for group, time, and the interaction of group-by-time with a random effect for score by participant ID.
SecondaryChange in Irritability

The Irritability subscale of the Aberrant Behavior Checklist, Second Edition (ABC-2) measures behaviors associated with irritability, including aggression, self-injury, tantrums, and mood instability. The subscale consists of 15 items, with total scores ranging from 0-45. Higher scores indicate greater irritability and more severe behavioral difficulties, while lower scores indicate less irritability and better behavioral functioning. Items are rated based on the presence and severity of behaviors, and item scores are summed to produce the subscale score.

Time frame:
Week 1 & Week 10
Reported as:
Least squares mean · Scores on a Scale
Change in Irritability
Scores on a ScaleOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Week 1 Irritability18.72 (16.09 to 21.34)17.69 (14.78 to 20.60)
Week 10 Irritability14.87 (12.25 to 17.5)13.76 (10.76 to 16.76)
Statistical analysis
  • Occupational Therapy Integrating Horses vs Occupational Therapy in a Clinic · Mixed Models Analysis · p = 0.966 · Mean difference (net): 0.09 · 95% CI -3.88 to 4.05Model included fixed effects for group, time, and the interaction of group-by-time with a random effect for score by participant ID.
  • Occupational Therapy Integrating Horses · Mixed Models Analysis · p = 0.005 · Mean difference (final values): -3.84Model included fixed effects for group, time, and the interaction of group-by-time with a random effect for score by participant ID.
SecondaryChange in Emotional Reactivity

The Emotional Reactivity subscale of the Emotion Dysregulation Inventory (EDI) measures the tendency to experience intense, rapidly escalating, and prolonged negative emotional responses. T-scores are standardized scores derived from the raw Emotional Reactivity score and have a mean of 50 and standard deviation of 10 in the normative sample. Higher T-scores indicate greater emotional reactivity and more severe emotion dysregulation, while lower T-scores indicate less emotional reactivity and better emotional regulation.

Time frame:
Week 1 & Week 10
Reported as:
Least squares mean · Scores on a scale
Change in Emotional Reactivity
Scores on a scaleOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Week 1 Emotional Reactivity66.60 (64.51 to 68.69)64.47 (62.15 to 66.79)
Week 10 Emotional Reactivity61.72 (59.62 to 63.81)61.63 (59.23 to 64.02)
Statistical analysis
  • Occupational Therapy Integrating Horses vs Occupational Therapy in a Clinic · Mixed Models Analysis · p = 0.216 · Mean difference (net): -2.05 · 95% CI -5.31 to 1.22Model included fixed effects for group, time, group x time interaction, and a random effect of subject to accomodate repeated measures.
  • Occupational Therapy Integrating Horses · Mixed Models Analysis · p = <0.001 · Mean difference (final values): -4.88Model included fixed effects for group, time, group x time interaction, and a random effect of subject to accomodate repeated measures.
SecondaryChange in Dysphoria

The Dysphoria subscale of the Emotion Dysregulation Inventory (EDI) measures symptoms of negative mood, including sadness, hopelessness, and emotional distress. T-scores are standardized scores derived from the raw Dysphoria score and have a mean of 50 and standard deviation of 10 in the normative sample. Higher T-scores indicate greater dysphoria and more severe negative mood symptoms, while lower T-scores indicate less dysphoria and better emotional well-being.

Time frame:
Week 1 & Week 10
Reported as:
Least squares mean · Scores on a Scale
Change in Dysphoria
Scores on a ScaleOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Week 1 Dysphoria60.24 (57.40 to 63.07)56.38 (53.24 to 59.53)
Week 10 Emotional Reactivity56.43 (53.59 to 59.26)53.50 (50.27 to 56.74)
Statistical analysis
  • Occupational Therapy Integrating Horses vs Occupational Therapy in a Clinic · Mixed Models Analysis · p = 0.662 · Mean difference (net): -0.93 · 95% CI -5.13 to 3.27Model included fixed effects for group, time, group x time interaction, and a random effect of subject to accomodate repeated measures.
  • Occupational Therapy Integrating Horses · Mixed Models Analysis · p = 0.008 · Mean difference (final values): -3.81Model included fixed effects for group, time, group x time interaction, and a random effect of subject to accomodate repeated measures.
SecondaryChange in Concentration of Salivary Cortisol

Change in Concentration of Salivary Cortisol from before-session, after-session, and 20 mins after-session. Saliva samples from Weeks 2, 6, and 10 at pre-session, post-session, and post-session +20, were assayed for cortisol content and included in the linear mixed model analyses.

Time frame:
Pre-session, Post-session, Post-session + 20 min, averaged across Intervention Weeks 2, 6 and 10
Reported as:
Geometric least squares mean · ug/dL
Change in Concentration of Salivary Cortisol
ug/dLOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Pre-session0.17 (0.14 to 0.20)0.16 (0.13 to 0.19)
Post-session0.11 (0.10 to 0.13)0.13 (0.10 to 0.15)
Post-session + 20 min0.11 (0.09 to 0.13)0.14 (0.11 to 0.16)
Statistical analysis
  • Occupational Therapy Integrating Horses vs Occupational Therapy in a Clinic · Mixed Models Analysis · p = <0.01 · Exponential estimates: 0.77 · 95% CI 0.63 to 0.93The exponential estimate 0.77 indicates the additional change in OT-Horse relative to OT-Clinic at Post-session + 20 mins.
SecondaryChange in Concentration of Salivary Alpha-amylase

Change in concentration of salivary alpha-amylase from before-session, during-session, and 20 mins after-session. Saliva samples from Weeks 2, 6, and 10 at pre-session, within-session, and post-session +20, were assayed for alpha-amylase content and included in the linear mixed model analyses.

Time frame:
Pre-session, Within-session, Post-session + 20 min, averaged across Intervention Weeks 2, 6 and 10
Reported as:
Geometric least squares mean · U/mL
Change in Concentration of Salivary Alpha-amylase
U/mLOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Pre-session79.57 (60.91 to 103.95)51.48 (37.82 to 70.08)
Within-session79.57 (60.91 to 103.95)63.00 (46.28 to 85.76)
Post-session + 20 min69.47 (53.19 to 90.74)56.00 (41.13 to 76.24)
Statistical analysis
  • Occupational Therapy Integrating Horses vs Occupational Therapy in a Clinic · Mixed Models Analysis · p = >0.05 · Exponential estimate: 0.99 · 95% CI 0.81 to 1.20Exponential estimate indicates the additional change in OT-Horse group relative to OT-Clinic at the within-session timepoint.
SecondaryEmotional Awareness Goal Attainment

Attainment of individualized emotional awareness goal. Goal attainment scales range from -2 to +2 where higher values indicate greater progress towards individual goal, level 0 indicates goal was met.

Time frame:
Week 10
Reported as:
Number · Proportion of Participants Who Met Goal
Emotional Awareness Goal Attainment
Proportion of Participants Who Met GoalOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Emotional Awareness Goal Attainment0.7190.696
Statistical analysis
  • Occupational Therapy Integrating Horses vs Occupational Therapy in a Clinic · Chi-squared · p = 0.852
SecondarySelf-regulation Tool Identification Goal Attainment

Attainment of individualized goal related to identifying self-regulation tools. Goal attainment scales range from -2 to +2 where higher values indicate greater progress towards individual goal, level 0 indicates goal was met.

Time frame:
Week 10
Reported as:
Number · Proportion of Participants Who Met Goal
Self-regulation Tool Identification Goal Attainment
Proportion of Participants Who Met GoalOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Self-regulation Tool Identification Goal Attainment0.9350.652
Statistical analysis
  • Occupational Therapy Integrating Horses vs Occupational Therapy in a Clinic · Fisher Exact · p = 0.012
SecondarySelf-regulation Tool Use Goal Attainment

Attainment of individualized goal related to using self-regulation tools. Goal attainment scales range from -2 to +2 where higher values indicate greater progress towards individual goal, level 0 indicates goal was met.

Time frame:
Week 10
Reported as:
Number · Proportion of Participants Who Met Goal
Self-regulation Tool Use Goal Attainment
Proportion of Participants Who Met GoalOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Self-regulation Tool Use Goal Attainment0.7190.609
Statistical analysis
  • Occupational Therapy Integrating Horses vs Occupational Therapy in a Clinic · Chi-squared · p = 0.391

Adverse events

Collected over From Week 1 to follow-up phone call that occurred up to 2-weeks after Week 10.. Non-serious events are listed at a 5% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Occupational Therapy Integrating Horses0/32 (0%)0/32 (0%)2/32 (6.3%)
Occupational Therapy in a Clinic0/24 (0%)0/24 (0%)1/24 (4.2%)
Most frequent other events
Most frequent other events
EventOccupational Therapy Integrating HorsesOccupational Therapy in a Clinic
Emotional Upset During TherapyGeneral disorders2/321/24

Baseline characteristics

Some participants (OT-Equine n=2; OT-Clinic n=12) withdrew after randomization prior to baseline assessments.

Age, Continuous
Age, Continuous(Years)Occupational Therapy Integrating HorsesOccupational Therapy in a ClinicTotal
Mean8.7 ± 1.79.2 ± 1.78.9 ± 1.7
Sex: Female, Male
Sex: Female, Male(Participants)Occupational Therapy Integrating HorsesOccupational Therapy in a ClinicTotal
Female10818
Male221840
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Occupational Therapy Integrating HorsesOccupational Therapy in a ClinicTotal
American Indian or Alaska Native000
Asian404
Native Hawaiian or Other Pacific Islander000
Black or African American112
White201838
More than one race5510
Unknown or Not Reported224
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Occupational Therapy Integrating HorsesOccupational Therapy in a ClinicTotal
Hispanic or Latino7714
Not Hispanic or Latino251944
Unknown or Not Reported000
ABAS-3 General Adaptive Composite
ABAS-3 General Adaptive Composite(Score on a Scale)Occupational Therapy Integrating HorsesOccupational Therapy in a ClinicTotal
Mean79.8 ± 8.875.4 ± 8.877.9 ± 9.0
08

Study locations

1 site
  • Temple Grandin Equine Center
    Denver, Colorado 80216, United States
09

References and documents

Publications

  • Rankins EM, Aichele S, Granger DA, Hepburn S, Gabriels R, Schmid AA, Peters BC. Effects of Incorporating Horses into Occupational Therapy on Adrenocortical and Sympathetic Nervous System Reactivity and Regulation in Autistic Children: A Randomized Controlled Trial. J Autism Dev Disord. 2026 Oct 10. doi: 10.1007/s10803-026-07540-9. Online ahead of print. PubMed 42859339 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — De-identified data will be shared in an appropriate data repository, such as the "Data and Specimen Hub" (DASH) or the "National Database for Autism Research" (NDAR). Data will be shared no later than the acceptance for publication of the main findings from the final dataset. Salimetrics will discard saliva samples after testing, and therefore saliva samples will not be available for sharing.

Supporting information: Informed consent form

Time frame: We will share in an appropriate data repository indefinitely, no later than the acceptance for publication of the main findings from the final dataset

10

Updates

1 registry update since Sep 25, 2026
Results
Results posted
posted Oct 2, 2026
Enrollment
73→72
Oct 2, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • ChangedBefore Change in Aberrant Behavior Checklist, CommunityNow Change in HyperactivityTime frame: Week 1 & Week 10
Oct 2, 2026
Secondary outcomes
1 edited, 2 time frame changed, 5 added, 1 removed, 2 description edited
What changed in the outcomes
  • EditedChange in Emotional Dysregulation InventoryIrritabilityTime frame: Week 1 & Week 10
  • AddedChange in Emotional ReactivityTime frame: Week 1 & Week 10
  • AddedChange in DysphoriaTime frame: Week 1 & Week 10
  • AddedEmotional Awareness Goal AttainmentTime frame: Week 10
  • AddedSelf-regulation Tool Identification Goal AttainmentTime frame: Week 10
  • AddedSelf-regulation Tool Use Goal AttainmentTime frame: Week 10
  • RemovedGoal Attainment using Goal Attainment ScaleTime frame: Week 10
  • Time frameChange in Concentration of Salivary CortisolWeek 1, Week 6, Week 10 → Pre-session, Post-session, Post-session + 20 min, averaged across Intervention Weeks 2, 6 and 10
  • Time frameChange in Concentration of Salivary Alpha-amylaseWeek 1, Week 6, Week 10 → Pre-session, Within-session, Post-session + 20 min, averaged across Intervention Weeks 2, 6 and 10
  • DescriptionChange in Concentration of Salivary Alpha-amylase: how it is measured was reworded
  • DescriptionChange in Concentration of Salivary Cortisol: how it is measured was reworded
Oct 2, 2026
Show all 1 update
  1. Oct 2, 2026
    Results posted
    Enrollment 73→72
    Primary outcomes 1 edited
    What changed in the outcomes
    • ChangedBefore Change in Aberrant Behavior Checklist, CommunityNow Change in HyperactivityTime frame: Week 1 & Week 10
    Secondary outcomes 1 edited, 2 time frame changed, 5 added, 1 removed, 2 description edited
    What changed in the outcomes
    • EditedChange in Emotional Dysregulation InventoryIrritabilityTime frame: Week 1 & Week 10
    • AddedChange in Emotional ReactivityTime frame: Week 1 & Week 10
    • AddedChange in DysphoriaTime frame: Week 1 & Week 10
    • AddedEmotional Awareness Goal AttainmentTime frame: Week 10
    • AddedSelf-regulation Tool Identification Goal AttainmentTime frame: Week 10
    • AddedSelf-regulation Tool Use Goal AttainmentTime frame: Week 10
    • RemovedGoal Attainment using Goal Attainment ScaleTime frame: Week 10
    • Time frameChange in Concentration of Salivary CortisolWeek 1, Week 6, Week 10 → Pre-session, Post-session, Post-session + 20 min, averaged across Intervention Weeks 2, 6 and 10
    • Time frameChange in Concentration of Salivary Alpha-amylaseWeek 1, Week 6, Week 10 → Pre-session, Within-session, Post-session + 20 min, averaged across Intervention Weeks 2, 6 and 10
    • DescriptionChange in Concentration of Salivary Alpha-amylase: how it is measured was reworded
    • DescriptionChange in Concentration of Salivary Cortisol: how it is measured was reworded
    + 2 other changes: verification date and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

11

Registry details

Key details

Study ID
NCT05846932
Responsible party
Sponsor
First posted
May 6, 2023
Start date
Mar 21, 2023
Primary completion
Apr 23, 2025
Completion
Nov 1, 2025
Results posted
Oct 2, 2026
Last update
Oct 2, 2026

Study contacts

Brittany C Peters, PhD
principal investigator · Colorado State University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion